AbbVie Inc. (ABBV) is currently trading at $206.69. Based on 29 Wall Street analysts, the average target price is $249.14, implying a 20.5% upside. The consensus recommendation is BUY.
ABBV
AbbVie Inc.
Opinion Criteria: Based on the consensus of Wall Street analysts. Strong Buy (1.0-1.5), Buy (1.5-2.5), Hold (2.5-3.5), Sell (3.5-4.5), Strong Sell (4.5-5.0).
Price (USD)
Avg Target
$249.14
Based on 29 analysts
Analyst Recommendations
Upside
+20.54%
Market Cap
$365.59B
Financial & Investment Metrics
Latest News
AbbVie (ABBV) Stock Drops Despite Market Gains: Important Facts to Note
How Will Skyrizi and Rinvoq Shape AbbVie's Q1 Immunology Sales?
High Yield vs. Sustainable Growth: Why AbbVie’s Dividend Beats Pfizer’s Despite the Lower Payout
Here's Why AbbVie (ABBV) is a Strong Value Stock
Stock Of The Day In Buy Zone, Leads Industry Despite Supersmall Market
Insider Sentiment Index (Last 6 Months)
Buy vs Sell (Count)
Whale Trades (C-Level Large Buys)
No major insider buying detected recently.
Recent Insider Transactions
| Date | Name | Position | Transaction | Shares |
|---|---|---|---|---|
| 3/4/2026 | PURDUE DAVID R. | Officer | Sale at price 233.56 per share. | 5,230 |
| 3/2/2026 | SIATIS PERRY C. | General Counsel | Sale at price 233.51 - 235.26 per share. | 18,668 |
| 2/25/2026 | SIATIS PERRY C. | General Counsel | Conversion of Exercise of derivative security at price 149.62 - 192.86 per share. | 22,381 |
| 2/25/2026 | SIATIS PERRY C. | General Counsel | Sale at price 230.00 per share. | 22,381 |
| 2/18/2026 | SALEKI-GERHARDT AZITA | Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | 36,811 |
| 2/18/2026 | REENTS SCOTT T. | Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 48,838 |
| 2/18/2026 | SIATIS PERRY C. | General Counsel | Stock Award(Grant) at price 0.00 per share. | 33,518 |
| 2/18/2026 | STEWART JEFFREY RYAN | Officer | Stock Award(Grant) at price 0.00 per share. | 53,749 |
| 2/18/2026 | DONOGHOE NICHOLAS | Officer | Stock Award(Grant) at price 0.00 per share. | 29,057 |
| 2/18/2026 | MICHAEL ROBERT A. | Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 82,439 |
Frequently Asked Questions
Q. What is the current target price and upside for ABBV?
A. The current target price for AbbVie Inc. is $249.14, which implies a 20.5% upside from the current price of $206.69. This is based on the consensus of 29 Wall Street analysts.
Q. What is the current analyst recommendation for ABBV?
A. Currently, there are 8 Strong Buy, 14 Buy, 9 Hold, 0 Sell, and 0 Strong Sell ratings. The overall consensus is BUY.
Q. Are insiders buying ABBV stock recently?
A. Over the past 6 months, there have been 10 insider buys and 3 insider sells. This can be interpreted as a positive signal.